| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sendek Joel | Chief Financial Officer | C/O PERSPECTIVE THERAPEUTICS, INC., 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE | /s/ Joel Sendek by Chris Nenno, as Attorney-in-Fact | 05 Sep 2025 | 0001720875 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CATX | Stock option (right to buy) | Award | $0 | +600,000 | $0.000000 | 600,000 | 04 Sep 2025 | Common Stock | 600,000 | $3.54 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The options vest over a four-year period, with one-fourth (1/4) vesting and becoming exercisable on September 4, 2026, and the remaining options vesting and becoming exercisable ratably over the following 36 months, subject to the continuous service of the Reporting Person as of each vesting date. |